Close Menu

NEW YORK — Novacyt said on Friday that its Primerdesign molecular testing business has signed a distribution deal for its products to the aquaculture and aquamarine markets in France with Atothis SARL.

Under the terms of the deal, Atothis — a unit of VGS Invest Holding Sarl Group — will distribute Primerdesign's Genesig q16 PCR instrument and related tests in France for use in the early detection of diseases that impact aquatic animal health during food production.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.

According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.

The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.

In Nature this week: the largest known collection of human genetic variants, and more.

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.